Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reo Maruyama

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
BMB Reports|November 29, 2012
Long noncoding RNA involvement in cancerReo Maruyama, Hiromu Suzuki
Frontiers in Genetics|December 19, 2013
Epigenetic alteration and microRNA dysregulation in cancerHiromu Suzuki, Reo Maruyama, Eiichiro Yamamoto, et al.
Molecular Oncology|August 21, 2012
DNA methylation and microRNA dysregulation in cancerHiromu Suzuki, Reo Maruyama, Eiichiro Yamamoto, et al.
Frontiers in Oncology|May 26, 2023
FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer-gene programs in basal-like breast cancerKohei Kumegawa, Liying Yang, Kenichi Miyata, et al.
Molecular Biology Reports|November 27, 2022
Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin openingTomoyoshi Nakadai, Liying Yang, Kohei Kumegawa, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 15, 2012
[Developing technologies for epigenomic analysis and clinical application of molecular diagnosis]Eiichiro Yamamoto, Hiromu Suzuki, Reo Maruyama, et al.
Biochemical and Biophysical Research Communications|July 25, 2020
HBx increases EGFR expression by inhibiting miR129-5p functionMasanori Ochi, Motoyuki Otsuka, Reo Maruyama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 6, 2012
Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancerReo Maruyama, Hiromu Suzuki, Eiichiro Yamamoto, et al.
Biochemical and Biophysical Research Communications|July 13, 2014
Biological significance of the CpG island methylator phenotypeHiromu Suzuki, Eiichiro Yamamoto, Reo Maruyama, et al.
Cancer Gene Therapy|March 1, 2024
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell linesLiying Yang, Kohei Kumegawa, Sumito Saeki, et al.
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
BMB Reports|November 29, 2012
Long noncoding RNA involvement in cancerReo Maruyama, Hiromu Suzuki
Frontiers in Genetics|December 19, 2013
Epigenetic alteration and microRNA dysregulation in cancerHiromu Suzuki, Reo Maruyama, Eiichiro Yamamoto, et al.
Molecular Oncology|August 21, 2012
DNA methylation and microRNA dysregulation in cancerHiromu Suzuki, Reo Maruyama, Eiichiro Yamamoto, et al.
Frontiers in Oncology|May 26, 2023
FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer-gene programs in basal-like breast cancerKohei Kumegawa, Liying Yang, Kenichi Miyata, et al.
Molecular Biology Reports|November 27, 2022
Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin openingTomoyoshi Nakadai, Liying Yang, Kohei Kumegawa, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 15, 2012
[Developing technologies for epigenomic analysis and clinical application of molecular diagnosis]Eiichiro Yamamoto, Hiromu Suzuki, Reo Maruyama, et al.
Biochemical and Biophysical Research Communications|July 25, 2020
HBx increases EGFR expression by inhibiting miR129-5p functionMasanori Ochi, Motoyuki Otsuka, Reo Maruyama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 6, 2012
Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancerReo Maruyama, Hiromu Suzuki, Eiichiro Yamamoto, et al.
Biochemical and Biophysical Research Communications|July 13, 2014
Biological significance of the CpG island methylator phenotypeHiromu Suzuki, Eiichiro Yamamoto, Reo Maruyama, et al.
Cancer Gene Therapy|March 1, 2024
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell linesLiying Yang, Kohei Kumegawa, Sumito Saeki, et al.
Pageof 13